G9654 – Monitored anesthesia care (mac)

Long description

Monitored anesthesia care (mac)

Short description

Mon anesth care

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2016

Last change

January 1, 2016 – No change

Nearby G codes

• G9646 – Patients with 90 day mrs score of 0 to 2
• G9647 – Patients in whom mrs score could not be obtained at 90 day follow-up
• G9648 – Patients with 90 day mrs score greater than 2
• G9649 – Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))
• G9650 – Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi
• G9651 – Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented
• G9652 – Patient has been treated with a systemic or biologic medication for psoriasis for at least six months
• G9653 – Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months
• G9655 – A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used
• G9656 – Patient transferred directly from anesthetizing location to pacu or other non-icu location
• G9657 – Transfer of care during an anesthetic or to the intensive care unit
• G9658 – A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used
• G9659 – Patients greater than or equal to 86 years of age who underwent a screening colonoscopy and did not have a history of colorectal cancer or other valid medical reason for the colonoscopy, including: iron deficiency anemia, lower gastrointestinal bleeding, familial adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits
• G9660 – Documentation of medical reason(s) for a colonoscopy performed on a patient greater than or equal to 86 years of age (e.g., iron deficiency anemia, lower gastrointestinal bleeding, familial history of adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits)
• G9661 – Patients greater than or equal to 86 years of age who received a colonoscopy for an assessment of signs/symptoms of gi tract illness, and/or because the patient meets high risk criteria, and/or to follow-up on previously diagnosed advanced lesions
• G9662 – Previously diagnosed or have a diagnosis of clinical ascvd, including ascvd procedure